Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 18/20 | 0.75 |
| ▸ | PTGDR2 | Q9Y5Y4 | 2/20 | 0.53 |
| ▸ | FPR3 | P25089 | 1/20 | 0.52 |
| ▸ | GPR65 | Q8IYL9 | 1/20 | 0.52 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5059532 | 0.93 | CCR1 (0.78) | CCR1PTGDR2FPR3GPR65GPR35 | |
| SCHEMBL6253576 | 0.92 | CCR1 (0.77) | CCR1PTGDR2FPR3GPR65GPR35 | |
| SCHEMBL6256531 | 0.92 | CCR1 (0.73) | CCR1PTGDR2FPR3GPR65GPR35 | |
| SCHEMBL6252447 | 0.92 | CCR1 (0.75) | CCR1PTGDR2FPR3GPR65GPR35 | |
| SCHEMBL6259499 | 0.91 | CCR1 (0.74) | CCR1PTGDR2FPR3GPR65GPR35 | |
| SCHEMBL6254136 | 0.90 | CCR1 (0.71) | CCR1PTGDR2FPR3GPR65GPR35 | |
| SCHEMBL6256840 | 0.90 | CCR1 (0.71) | CCR1PTGDR2FPR3GPR65GPR35 | |
| SCHEMBL5056373 | 0.90 | CCR1 (0.73) | CCR1PTGDR2FPR3GPR65GPR35 | |
| SCHEMBL4588019 | 0.89 | CCR1 (0.82) | CCR1PTGDR2FPR3GPR65GPR35 | |
| SCHEMBL4588012 | 0.89 | CCR1 (0.82) | CCR1PTGDR2FPR3GPR65GPR35 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040127465-A1 | Novel phosphorus-containing derivatives | PFIZER INC | 2004-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040127465-A1 | Novel phosphorus-containing derivatives | SLC34A2, SLC34A1, SLC20A1 | CCR1 39/4885PTGDR2 770/4885FPR3 217/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.